Quinton R, Duke V M, Robertson A, Kirk J M, Matfin G, de Zoysa P A, Azcona C, MacColl G S, Jacobs H S, Conway G S, Besser M, Stanhope R G, Bouloux P M
Department of Endocrinology, Royal Victoria Infirmary, Newcastle-upon-Tyne, UK.
Clin Endocrinol (Oxf). 2001 Aug;55(2):163-74. doi: 10.1046/j.1365-2265.2001.01277.x.
The association of idiopathic hypogonadotrophic hypogonadism (IHH) with congenital olfactory deficit defines Kallmann's syndrome (KS). Although a small proportion of IHH patients have been found to harbour defined genetic lesions, the genetic basis of most IHH cases remains to be elucidated. Genes currently recognized to be involved comprise KAL (associated with X-linked-KS), the GnRH receptor (associated with resistance to GnRH therapy), DAX 1 (associated with adrenohypoplasia congenita) and three loci also associated with obesity, leptin (OB), leptin receptor (DB) and prohormone convertase (PC1). Because of the rarity of the condition and the observation that patients are almost universally infertile without assistance, familial transmission of IHH is encountered infrequently and pedigrees tend to be small. This has constrained the ability of conventional linkage studies to identify other candidate loci for genetic IHH. We hypothesized that a systematic clinical evaluation of a large patient sample might provide new insights into the genetics of this rare disorder. Specifically, we wished to examine the following propositions. First, whether normosmic (nIHH) and anosmic (KS) forms of IHH were likely to be genetically discrete entities, on the basis of quantitative olfactory testing, analysis of autosomal pedigrees and the prevalence of developmental defects such as cryptorchidism and cleft palate. Second, whether mirror movements and/or unilateral renal agenesis were specific phenotypic markers for X-linked-KS.
We conducted a clinical study of 170 male and 45 female IHH patients attending the endocrinology departments of three London University teaching hospitals. Approximately 80% of data were obtained from case records and 20% collected prospectively. Parameters assessed included olfaction, testicular volume, family history of hypogonadism, anosmia or pubertal delay, and history or presence of testicular maldescent, neurological, renal or craniofacial anomalies. Where possible, the clinical information was correlated with published data on genetic analysis of the KAL locus.
Olfactory acuity was bimodally distributed with no evidence for a spectrum of olfactory deficit. Testicular volume, a marker of integrated gonadotrophin secretion, did not differ significantly between anosmic and normosmic patients, at 2.0 ml and 2.2 ml, respectively. Nevertheless, the prevalence of cryptorchidism was nearly three times greater in anosmic (70.3%, of which 75.0% bilateral) than in normosmic (23.2%, of which 43.8% bilateral) patients. Individuals with nIHH, eugonadal isolated anosmia and/or KS were observed to coexist within 6/13 autosomal IHH pedigrees. On three occasions, fertility treatment given to an IHH patient had resulted in the condition being transmitted to the resulting offspring. Mirror movements and unilateral renal agenesis were observed in 24/98 and 9/87 IHH patients, respectively, all of whom were identifiable as X-KS males on the basis of pedigree analysis and/or defective KAL coding sequence. Abnormalities of eye movement and unilateral sensorineural deafness were observed in 10/21 and 6/111 KS patients, respectively, but not in nIHH patients.
Patients with IHH are almost invariably either anosmic (KS) or normosmic (nIHH), rather than exhibiting intermediate degrees of olfactory deficit. Moreover, the prevalence of cryptorchidism is nearly three times greater in KS than in nIHH despite comparable testicular volumes, suggesting a primary defect of testicular descent in KS independent of gonadotrophin deficiency. Disorders of eye movement and hearing appear only to occur in association with KS. Taken together, these findings indicate a clear phenotypic separation between KS and nIHH. However, pedigree studies suggest that autosomal KS is an heterogeneous condition, with incomplete phenotypic penetrance within pedigrees, and that some cases of autosomal KS, nIHH and even isolated anosmia are likely to have a common genetic basis. The prevalences of anosmia, mirror movements and unilateral renal agenesis among X-KS men are estimated to be 100, 85 and 31%, respectively. In sporadic IHH, mirror movements and unilateral renal agenesis are 100% specific phenotypic markers of de novo X-KS. By comparison, only 7/10 X-KS families harboured KAL coding defects. Clinical ascertainment, using mirror movements, renal agenesis and ichthyosis as X-KS-specific phenotypic markers, suggested that de novo X-KS was unlikely to comprise more than 11% of sporadic cases. The majority of sporadic KS cases are therefore presumed to have an autosomal basis and, hence, the preponderance of affected KS males over females remains unexplained, though reduced penetrance in women would be a possibility.
特发性低促性腺激素性性腺功能减退症(IHH)与先天性嗅觉缺失相关,此即卡尔曼综合征(KS)。尽管已发现一小部分IHH患者存在明确的基因病变,但大多数IHH病例的遗传基础仍有待阐明。目前认为与之相关的基因包括KAL(与X连锁KS相关)、促性腺激素释放激素(GnRH)受体(与GnRH治疗抵抗相关)、DAX1(与先天性肾上腺发育不全相关)以及另外三个也与肥胖相关的基因座,即瘦素(OB)、瘦素受体(DB)和激素原转化酶(PC1)。由于该病罕见,且患者若无辅助几乎普遍不育,因此很少遇到IHH的家族性传递,家系往往较小。这限制了传统连锁研究识别遗传性IHH其他候选基因座的能力。我们推测,对大量患者样本进行系统的临床评估可能会为这种罕见疾病的遗传学提供新见解。具体而言,我们希望检验以下命题。第一,基于定量嗅觉测试、常染色体家系分析以及隐睾和腭裂等发育缺陷的患病率,IHH的嗅觉正常型(nIHH)和嗅觉缺失型(KS)是否可能是基因上不同的实体。第二,镜像运动和/或单侧肾发育不全是否是X连锁KS的特异性表型标志物。
我们对伦敦三所大学教学医院内分泌科的170例男性和45例女性IHH患者进行了临床研究。约80%的数据来自病例记录,20%为前瞻性收集。评估的参数包括嗅觉、睾丸体积、性腺功能减退、嗅觉缺失或青春期延迟的家族史,以及睾丸未降、神经、肾脏或颅面异常的病史或存在情况。在可能的情况下,将临床信息与已发表的关于KAL基因座遗传分析的数据进行关联。
嗅觉敏锐度呈双峰分布,没有证据表明存在一系列嗅觉缺失情况。睾丸体积作为促性腺激素综合分泌的标志,嗅觉缺失患者和嗅觉正常患者之间无显著差异,分别为2.0毫升和2.2毫升。然而,嗅觉缺失患者中隐睾的患病率(70.3%,其中双侧隐睾占75.0%)几乎是嗅觉正常患者(23.2%,其中双侧隐睾占43.8%)的三倍。在13个常染色体IHH家系中的6个家系中,观察到nIHH、性腺功能正常的单纯嗅觉缺失和/或KS患者共存。有三次,给一名IHH患者进行生育治疗导致该病遗传给了后代。在98例IHH患者中有24例观察到镜像运动,在87例IHH患者中有9例观察到单侧肾发育不全,根据家系分析和/或KAL编码序列缺陷,所有这些患者均可确定为X连锁KS男性。在21例KS患者中有10例观察到眼球运动异常,在111例KS患者中有6例观察到单侧感觉神经性耳聋,但在nIHH患者中未观察到。
IHH患者几乎总是要么嗅觉缺失(KS)要么嗅觉正常(nIHH),而不是表现出中间程度的嗅觉缺失。此外,尽管睾丸体积相当,但KS患者中隐睾的患病率几乎是nIHH患者的三倍,这表明KS中睾丸下降的原发性缺陷独立于促性腺激素缺乏。眼球运动和听力障碍似乎仅与KS相关。综上所述,这些发现表明KS和nIHH之间存在明显的表型分离。然而,家系研究表明,常染色体KS是一种异质性疾病,在家系中表型外显不完全,并且一些常染色体KS、nIHH甚至单纯嗅觉缺失病例可能具有共同的遗传基础。估计X连锁KS男性中嗅觉缺失、镜像运动和单侧肾发育不全的患病率分别为100%、85%和31%。在散发性IHH中,镜像运动和单侧肾发育不全是新生X连锁KS的100%特异性表型标志物。相比之下,10个X连锁KS家族中只有7个存在KAL编码缺陷。使用镜像运动、肾发育不全和鱼鳞病作为X连锁KS特异性表型标志物进行临床确诊表明,新生X连锁KS不太可能占散发病例的11%以上。因此,大多数散发性KS病例被认为具有常染色体基础,因此,尽管女性外显率可能降低,但受影响的KS男性多于女性的现象仍无法解释。